1,145
Views
16
CrossRef citations to date
0
Altmetric
Case Report

Sibutramine-induced acute myocardial infarction in a young lady

, , , &
Pages 877-879 | Received 16 Jan 2008, Accepted 17 Apr 2008, Published online: 02 Dec 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Defne Eraslan, Aylin Aksoy Coban & Erhan Ertekin. (2015) Panic Disorder Induced by a “Herbal” Product Containing Sibutramine: Case Series with Review of Literature. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 25:1, pages 74-77.
Read now
Fábio Bucaretchi, Eduardo Mello de Capitani, Sueli Moreira Mello, Rafael Lanaro, Roberta F. Barros, Luciane C.R. Fernandes, JosÉ Luiz DA Costa & Stephen Hyslop. (2009) Serotonin syndrome following sibutramine poisoning in a child, with sequential quantification of sibutramine and its primary and secondary amine metabolites in plasma. Clinical Toxicology 47:6, pages 598-601.
Read now

Articles from other publishers (14)

Miguel Rodriguez-Guerra, Mayank Yadav, Manoj Bhandari, Archna Sinha, Jonathan N. Bella & Eduard Sklyar. (2021) Sibutramine as a Cause of Sudden Cardiac Death. Case Reports in Cardiology 2021, pages 1-5.
Crossref
Dan Osei Mensah Bonsu, Constance Afoakwah & Maria de la Paz Aguilar-Caballos. (2021) Counterfeit formulations: analytical perspective on anorectics. Forensic Toxicology 39:1, pages 1-25.
Crossref
Chun-Wei Tung. (2015) ChemDIS: a chemical–disease inference system based on chemical–protein interactions. Journal of Cheminformatics 7:1.
Crossref
Seung Hye HeoMin-Ho Kang. (2013) A Case of Dilated Cardiomyopathy with Massive Left Ventricular Thrombus after Use of a Sibutramine-Containing Slimming Product. Korean Circulation Journal 43:9, pages 632.
Crossref
SK Lam, OF Wong, HT Fung & PW Yam. (2017) Sibutramine Associated Cardiac Arrest in a Chinese Healthy Young Lady. Hong Kong Journal of Emergency Medicine 20:1, pages 45-49.
Crossref
Hannah C. JarvisJames R. Gill. (2012) Two Fatalities Associated with Sibutramine. Academic Forensic Pathology 2:4, pages 370-373.
Crossref
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse 255 274 .
YC Chan, ML Tse & FL Lau. (2017) Hong Kong Poison Information Centre: Annual Report 2009. Hong Kong Journal of Emergency Medicine 18:4, pages 221-231.
Crossref
André J. Scheen. (2011) Sibutramine on Cardiovascular Outcome. Diabetes Care 34:Supplement_2, pages S114-S119.
Crossref
A.J. Scheen. (2010) Cardiovascular Risk-Benefit Profile of Sibutramine. American Journal Cardiovascular Drugs 10:5, pages 321-334.
Crossref
José J. Gómez-Barrado, Soledad Turégano, Francisco J. Garcipérez de Vargas & Yolanda Porras. (2010) Acute Coronary Syndrome in a Young Woman Treated With Sibutramine. Revista Española de Cardiología (English Edition) 63:2, pages 242-243.
Crossref
José J. Gómez-Barrado, Soledad Turégano, Francisco J. Garcipérez de Vargas & Yolanda Porras. (2010) Síndrome coronario agudo en mujer joven tratada con sibutramina. Revista Española de Cardiología 63:2, pages 243.
Crossref
K A Kim, W K Song & J Y Park. (2009) Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects. Clinical Pharmacology & Therapeutics 86:5, pages 511-518.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.